| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Department of Toxicology, National Institute of Occupational Health, N-0033 Oslo, Norway [S. M., D. R., Al. H.], and Section of Molecular Carcinogenesis, Institute of Cancer Research, Surrey SM2 5N6, United Kingdom [Aa. H., D. H. P.]
Several epidemiological studies have indicated that female tobacco smokers may be at higher risk of lung cancer than males. In a study of lung cancer cases, we have found that female smokers had a significantly higher level of aromatic/hydrophobic DNA adducts in their nontumor lung tissue (15.39 ± 9.47 adducts/108 nucleotides, n = 29) than male smokers (12.08 ± 8.14, n = 93; P = 0.047). Females had significantly higher levels of adducts/pack-year (females 0.95 ± 0.82 adducts/pack-year and males 0.46 ± 0.46; P = 0.0004) and adducts/cigarette/day (females 1.48 ± 1.29 and males 0.89 ± 0.74, P = 0.015). By quantitative reverse transcription-PCR, it was found that female smokers exhibited a significantly higher expression level of lung CYP1A1 (494 ± 334 CYP1A1 mRNA/106 glyceraldehyde-3-phophate dehydrogenase mRNA, n = 15) compared with males (210 ± 208, n = 12; P = 0.016). Furthermore, for both sexes combined a significant correlation between CYP1A1 expression and DNA adduct level was found (r = 0.50, P = 0.009). In conclusion, the observed sex difference in aromatic/hydrophobic DNA adduct levels may at least in part be explained by different levels of CYP1A1 expression.
This article has been cited by other articles:
![]() |
R. Singhal, K. Shankar, T. M. Badger, and M. J. Ronis Estrogenic status modulates aryl hydrocarbon receptor--mediated hepatic gene expression and carcinogenicity Carcinogenesis, February 1, 2008; 29(2): 227 - 236. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Schwartz, A. S. Wenzlaff, G. M. Prysak, V. Murphy, M. L. Cote, S. C. Brooks, D. F. Skafar, and F. Lonardo Reproductive Factors, Hormone Use, Estrogen Receptor Expression and Risk of Non Small-Cell Lung Cancer in Women J. Clin. Oncol., December 20, 2007; 25(36): 5785 - 5792. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Sin, S. B.-Z. Cohen, A. Day, H. Coxson, and P. D. Pare Understanding the Biological Differences in Susceptibility to Chronic Obstructive Pulmonary Disease between Men and Women Proceedings of the ATS, December 1, 2007; 4(8): 671 - 674. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Tammemagi, M. T. Freedman, T. R. Church, M. M. Oken, W. G. Hocking, P. A. Kvale, P. Hu, T. L. Riley, L. R. Ragard, P. C. Prorok, et al. Factors Associated with Human Small Aggressive Non Small Cell Lung Cancer Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 2082 - 2089. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Jiang, J.-M. Yuan, P. L. Skipper, S. R. Tannenbaum, and M. C. Yu Environmental Tobacco Smoke and Bladder Cancer Risk in Never Smokers of Los Angeles County Cancer Res., August 1, 2007; 67(15): 7540 - 7545. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ben-Zaken Cohen, P. D. Pare, S. F. P. Man, and D. D. Sin The Growing Burden of Chronic Obstructive Pulmonary Disease and Lung Cancer in Women: Examining Sex Differences in Cigarette Smoke Metabolism Am. J. Respir. Crit. Care Med., July 15, 2007; 176(2): 113 - 120. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Wisnivesky and E. A. Halm Sex Differences in Lung Cancer Survival: Do Tumors Behave Differently in Elderly Women? J. Clin. Oncol., May 1, 2007; 25(13): 1705 - 1712. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Gallagher, J. E. Muscat, A. N. Hicks, Y. Zheng, A.-M. Dyer, G. A. Chase, J. Richie, and P. Lazarus The UDP-Glucuronosyltransferase 2B17 Gene Deletion Polymorphism: Sex-Specific Association with Urinary 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol Glucuronidation Phenotype and Risk for Lung Cancer Cancer Epidemiol. Biomarkers Prev., April 1, 2007; 16(4): 823 - 828. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mielzynska, E. Siwinska, L. Kapka, K. Szyfter, L. E. Knudsen, and D. F. Merlo The influence of environmental exposure to complex mixtures including PAHs and lead on genotoxic effects in children living in Upper Silesia, Poland Mutagenesis, September 1, 2006; 21(5): 295 - 304. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M Dougherty, W. Mazhawidza, A. R Bohn, K. A Robinson, K. A Mattingly, K. A Blankenship, M. O Huff, W. G McGregor, and C. M Klinge Gender difference in the activity but not expression of estrogen receptors {alpha} and {beta} in human lung adenocarcinoma cells. Endocr. Relat. Cancer, March 1, 2006; 13(1): 113 - 134. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zienolddiny, D. Campa, H. Lind, D. Ryberg, V. Skaug, L. Stangeland, D. H. Phillips, F. Canzian, and A. Haugen Polymorphisms of DNA repair genes and risk of non-small cell lung cancer Carcinogenesis, March 1, 2006; 27(3): 560 - 567. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Schwartz, G. M. Prysak, V. Murphy, F. Lonardo, H. Pass, J. Schwartz, and S. Brooks Nuclear Estrogen Receptor {beta} in Lung Cancer: Expression and Survival Differences by Sex Clin. Cancer Res., October 15, 2005; 11(20): 7280 - 7287. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Airoldi, P. Vineis, A. Colombi, L. Olgiati, C. Dell'Osta, R. Fanelli, L. Manzi, F. Veglia, H. Autrup, A. Dunning, et al. 4-Aminobiphenyl-Hemoglobin Adducts and Risk of Smoking-Related Disease in Never Smokers and Former Smokers in the European Prospective Investigation into Cancer and Nutrition Prospective Study Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2118 - 2124. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Thomas, L. A. Doyle, and M. J. Edelman Lung Cancer in Women: Emerging Differences in Epidemiology, Biology, and Therapy Chest, July 1, 2005; 128(1): 370 - 381. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Wasswa-Kintu, W Q Gan, S F P Man, P D Pare, and D D Sin Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis Thorax, July 1, 2005; 60(7): 570 - 575. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Shi, Z. Zhang, G. Li, P. C. Pillow, L. M. Hernandez, M. R. Spitz, and Q. Wei Sex Differences in Risk of Lung Cancer Associated with Methylene-tetrahydrofolate Reductase Polymorphisms Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1477 - 1484. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Patel Lung Cancer in Women J. Clin. Oncol., May 10, 2005; 23(14): 3212 - 3218. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Schabath, G. L. Delclos, H. B. Grossman, Y. Wang, S. P. Lerner, R. M. Chamberlain, M. R. Spitz, and X. Wu Polymorphisms in XPD Exons 10 and 23 and Bladder Cancer Risk Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 878 - 884. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Marrogi, L. E. Mechanic, J. A. Welsh, E. D. Bowman, M. A. Khan, L. Enewold, P. G. Shields, and C. C. Harris TP53 Mutation Spectrum in Lung Cancer Is Not Different in Women and Men Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 1031 - 1033. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Barnes The Changing Face of Lung Cancer Chest, December 1, 2004; 126(6): 1718 - 1721. [Full Text] [PDF] |
||||
![]() |
Aspen Cancer Conference Fellows Toxicol Pathol, October 1, 2004; 32(6): 749 - 761. [PDF] |
||||
![]() |
J. Olak and Y. Colson Gender differences in lung cancer: Have we really come a long way, baby? J. Thorac. Cardiovasc. Surg., September 1, 2004; 128(3): 346 - 351. [Full Text] [PDF] |
||||
![]() |
J. D. Patel, P. B. Bach, and M. G. Kris Lung Cancer in US Women: A Contemporary Epidemic JAMA, April 14, 2004; 291(14): 1763 - 1768. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Spivack, G. J. Hurteau, M. J. Fasco, and L. S. Kaminsky Phase I and II Carcinogen Metabolism Gene Expression in Human Lung Tissue and Tumors Clin. Cancer Res., December 1, 2003; 9(16): 6002 - 6011. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Warner, E. L. Crawford, A. Zaher, R. J. Coombs, H. Elsamaloty, S. L. Roshong-Denk, I. Sharief, G. V. Amurao, Y. Yoon, A. Y. Al-Astal, et al. The c-myc x E2F-1/p21 Interactive Gene Expression Index Augments Cytomorphologic Diagnosis of Lung Cancer in Fine-Needle Aspirate Specimens J. Mol. Diagn., August 1, 2003; 5(3): 176 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. H. Chang, J. Chen, V. Pillay, J.-Y. Ho, and S. M. Bandiera Real-Time Polymerase Chain Reaction Analysis of CYP1B1 Gene Expression in Human Liver Toxicol. Sci., January 1, 2003; 71(1): 11 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Lin, S.-W. Hu, and T.-H. Chang Correlation between Gene Expression of Aryl Hydrocarbon Receptor (AhR), Hydrocarbon Receptor Nuclear Translocator (Arnt), Cytochromes P4501A1 (CYP1A1) and 1B1 (CYP1B1), and Inducibility of CYP1A1 and CYP1B1 in Human Lymphocytes Toxicol. Sci., January 1, 2003; 71(1): 20 - 26. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Alexandrov, I. Cascorbi, M. Rojas, G. Bouvier, E. Kriek, and H. Bartsch CYP1A1 and GSTM1 genotypes affect benzo[a]pyrene DNA adducts in smokers' lung: comparison with aromatic/hydrophobic adduct formation Carcinogenesis, December 1, 2002; 23(12): 1969 - 1977. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Phillips Smoking-related DNA and protein adducts in human tissues Carcinogenesis, December 1, 2002; 23(12): 1979 - 2004. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Harada, S. Toyooka, N. Shivapurkar, A. Maitra, J. L. Reddy, H. Matta, K. Miyajima, C. F. Timmons, G. E. Tomlinson, D. Mastrangelo, et al. Deregulation of Caspase 8 and 10 Expression in Pediatric Tumors and Cell Lines Cancer Res., October 15, 2002; 62(20): 5897 - 5901. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. P. Perera, L. A. Mooney, M. Stampfer, D. H. Phillips, D. A. Bell, A. Rundle, S. Cho, W.-Y. Tsai, J. Ma, A. Blackwood, et al. Associations between carcinogen-DNA damage, glutathione S-transferase genotypes, and risk of lung cancer in the prospective Physicians' Health Cohort Study Carcinogenesis, October 1, 2002; 23(10): 1641 - 1646. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Banerjee, C. Bueso-Ramos, and B. B. Aggarwal Suppression of 7,12-Dimethylbenz(a)anthracene-induced Mammary Carcinogenesis in Rats by Resveratrol: Role of Nuclear Factor-{kappa}B, Cyclooxygenase 2, and Matrix Metalloprotease 9 Cancer Res., September 1, 2002; 62(17): 4945 - 4954. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. P. Stabile, A. L. G. Davis, C. T. Gubish, T. M. Hopkins, J. D. Luketich, N. Christie, S. Finkelstein, and J. M. Siegfried Human Non-Small Cell Lung Tumors and Cells Derived from Normal Lung Express Both Estrogen Receptor {alpha} and {beta} and Show Biological Responses to Estrogen Cancer Res., April 1, 2002; 62(7): 2141 - 2150. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Haugen Women who smoke: are women more susceptible to tobacco-induced lung cancer? Carcinogenesis, February 1, 2002; 23(2): 227 - 229. [Full Text] [PDF] |
||||
![]() |
S. A. Khuder and A. B. Mutgi Effect of Smoking Cessation on Major Histologic Types of Lung Cancer Chest, November 1, 2001; 120(5): 1577 - 1583. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Georgiadis, J. Topinka, M. Stoikidou, S. Kaila, M. Gioka, K. Katsouyanni, R. Sram, H. Autrup, and S. A. Kyrtopoulos Biomarkers of genotoxicity of air pollution (the AULIS project): bulky DNA adducts in subjects with moderate to low exposures to airborne polycyclic aromatic hydrocarbons and their relationship to environmental tobacco smoke and other parameters Carcinogenesis, September 1, 2001; 22(9): 1447 - 1457. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Tang, D. H. Phillips, M. Stampfer, L. A. Mooney, Y. Hsu, S. Cho, W.-Y. Tsai, J. Ma, K. J. Cole, M. N. She, et al. Association between Carcinogen-DNA Adducts in White Blood Cells and Lung Cancer Risk in the Physicians Health Study Cancer Res., September 1, 2001; 61(18): 6708 - 6712. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. B. J. Smith, P. A. Harper, J. M. Y. Wong, M. S. M. Lam, K. R. Reid, D. Petsikas, and T. E. Massey Human Lung Microsomal Cytochrome P4501A1 (CYP1A1) Activities: Impact of Smoking Status and CYP1A1, Aryl Hydrocarbon Receptor, and Glutathione S-Transferase M1 Genetic Polymorphisms Cancer Epidemiol. Biomarkers Prev., August 1, 2001; 10(8): 839 - 853. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Obach Cytochrome P450-Catalyzed Metabolism of Ezlopitant Alkene (CJ-12,458), a Pharmacologically Active Metabolite of Ezlopitant: Enzyme Kinetics and Mechanism Of an Alkene Hydration Reaction Drug Metab. Dispos., July 1, 2001; 29(7): 1057 - 1067. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. O. Toyooka, S. Toyooka, A. K. Virmani, U. G. Sathyanarayana, D. M. Euhus, M. Gilcrease, J. D. Minna, and A. F. Gazdar Loss of Expression and Aberrant Methylation of the CDH13 (H-Cadherin) Gene in Breast and Lung Carcinomas Cancer Res., June 1, 2001; 61(11): 4556 - 4560. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Castelao, J.-M. Yuan, P. L. Skipper, S. R. Tannenbaum, M. Gago-Dominguez, J. S. Crowder, R. K. Ross, and M. C. Yu Gender- and Smoking-Related Bladder Cancer Risk J Natl Cancer Inst, April 4, 2001; 93(7): 538 - 545. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.A. Williams Single nucleotide polymorphisms, metabolic activation and environmental carcinogenesis: why molecular epidemiologists should think about enzyme expression Carcinogenesis, February 1, 2001; 22(2): 209 - 214. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Goth-Goldstein, M. R. Stampfer, C. A. Erdmann, and M. Russell Interindividual variation in CYP1A1 expression in breast tissue and the role of genetic polymorphism Carcinogenesis, November 1, 2000; 21(11): 2119 - 2122. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Lampe, I. B. King, S. Li, M. T. Grate, K. V. Barale, C. Chen, Z. Feng, and J. D. Potter Brassica vegetables increase and apiaceous vegetables decrease cytochrome P450 1A2 activity in humans: changes in caffeine metabolite ratios in response to controlled vegetable diets Carcinogenesis, June 1, 2000; 21(6): 1157 - 1162. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. P. Perera Molecular Epidemiology: On the Path to Prevention? J Natl Cancer Inst, April 19, 2000; 92(8): 602 - 612. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Bartsch, U. Nair, A. Risch, M. Rojas, H. Wikman, and K. Alexandrov Genetic Polymorphism of CYP Genes, Alone or in Combination, as a Risk Modifier of Tobacco-related Cancers Cancer Epidemiol. Biomarkers Prev., January 1, 2000; 9(1): 3 - 28. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |